Understanding the new Kleresca Skin Rejuvenation
5 April 2018
One of newest offerings here at NBLDC is biophotonic technology for gentle skin rejuvenation, using Kleresca light technology.
If you’ve been to see us regarding acne, we may have mentioned the Kleresca light technology to you, as it was developed as a tool for treating acne in teens and adults. They also discovered that it improved skin tone and appearance generally.
Fast forward a few years and a bunch more research, and we now have the ability to offer gentle skin brightening and improvement using the same machine and process.
Does the world of dermatology need a new facial rejuvenation technique?
It’s true to say we already have a wide range of rejuvenation options available to us. From gentle chemical peels, through tailored Walter-Nolan procedures, right up to serious resurfacing with our CO2 laser, we’ve been offering patients a range of rejuvenation options for many years.
What the Kleresca system brings to the table is a more effective result at the gentle end of rejuvenation (compared to a chemical peel) but without the downtime or potential side effects of a more serious laser rejuvenation.
This is a welcome balance for many patients, as the treatment itself takes 9 minutes under the light, and about 30 minutes all up, including preparation and post-treatment moisturising, application of sunscreen and make up, before walking out into your life once more. You may see results after only a single treatment, with the recommended number being 4 treatments (once a week).
How does it work?
A specially formulated gel is applied to the skin, through which the Kleresca LED light can to act on the skin. This process, called biophotonics, activates the skin’s own biological processes and can induce natural improvement in quality and appearance. This is a relatively new phenomenon in cosmetic dermatology, available only since 2014.
NBLDC was the first dermatology practice to start using biophotonics, when Kleresca first launched in Australia in 2016. Since then, with repeated training and new research from our partners at Kleresca, our staff are now experts in administering this technology safely and effectively.
But it’s not right for every patient
As with any treatment, there are patients for whom Kleresca facial rejuvenation may not be an appropriate choice.
Those who suffer from melasma (hormonal pigmentation) can experience increased pigmentation when exposed to biophotonic light, and it is not a recommended treatment for those patients.
Patients seeking a deeper or more thorough skin rejuvenation will be directed to a laser-based option, as results from those more invasive techniques will be greater and longer lasting, so represent greater value for the patient.
Ready to rejuv your skin with Kleresca?
As with all our skin rejuvenation procedures, we highly recommend that our patients have a consultation with our Dermatologist, who will review your skin, ensuring that no underlying conditions or problems exist that may inhibit the success of the rejuvenation or which may be exacerbated by being exposed to the treatment. The Dermatologist will also advise you on what results you can expect from this treatment, and whether a different treatment might be better suited to achieving the results you desire.
Written by Dr Marianne Nolan and Naomi Crain.
Dr Marianne is a cosmetic physician and has a particular interest in injectables and skin rejuvenation.